These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7036933)

  • 21. [Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
    Zech PY; Trotta P; Labeeuw M
    Nouv Presse Med; 1981 Apr; 10(19):1571-4. PubMed ID: 7025847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension].
    Zebrowska-Lupina I; Kolber-Postepska B; Markiewicz M; Horubała-Bielak G
    Wiad Lek; 1994 Apr; 47(7-8):241-7. PubMed ID: 7941572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B; Brunner HR; Burckhardt P; Gavras H
    Arch Intern Med; 1982 Jan; 142(1):143-5. PubMed ID: 7032443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with captopril of idiopathic edemas (author's transl)].
    Mimran A
    Nouv Presse Med; 1981 Apr; 10(19):1594-5. PubMed ID: 7025852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents].
    Bussien JP; Schaller MD; Nussberger J; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1984 Feb; 114(7):236-9. PubMed ID: 6322293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
    Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
    Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
    [No Abstract]   [Full Text] [Related]  

  • 30. Review of the overall experience of captopril in hypertension.
    Frohlich ED; Cooper RA; Lewis EJ
    Arch Intern Med; 1984 Jul; 144(7):1441-4. PubMed ID: 6233948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril-associated granulocytopenia in hypertension after renal transplantation.
    Shindo K; Matsuya F; Ura T; Jodai A; Shimomae H; Kuniyoshi M; Hirose T; Kusaba Y; Saito Y
    Clin Nephrol; 1984 Dec; 22(6):314-6. PubMed ID: 6396008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of captopril therapy of arterial hypertension in children with terminal renal failure].
    Gura C; Sieniawska M; Welc-Dobies J
    Pediatr Pol; 1985 Feb; 60(2):177-85. PubMed ID: 3895149
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of hypertension with captopril].
    Ploos van Amstel SL; Abbad FC
    Tijdschr Kindergeneeskd; 1984 Dec; 52(6):227-31. PubMed ID: 6396899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril-induced deterioration of graft function in patients with a transplant renal artery stenosis.
    van Son WJ; van der Woude FJ; Tegzess AM; Donker AJ; Slooff MJ; van der Slikke LB; Hoorntje SJ
    Proc Eur Dial Transplant Assoc; 1983; 20():325-30. PubMed ID: 6361746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term hemodynamic response to captopril (SQ 14,225) in hypertensive hemodialysis patients.
    Hirakata H; Iseki K; Onoyama K; Kumagai H; Fujimi S; Omae T
    Clin Nephrol; 1983 Feb; 19(2):87-91. PubMed ID: 6340877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes of components in the kinin system and plasma renin activity during different stages of hypertension in patients treated with captopril].
    Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):245-8. PubMed ID: 7862589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.